Nexo Therapeutics

Developer of a molecule oncology platform designed to advance the development of small-molecule therapies for patients with limited treatment options. The company's platform combines the power of covalent ligand discovery and chemical biology to unlock a pipeline of novel oncology therapies directed against previously intractable targets, enabling medical professionals to provide new treatment options for cancer and other diseases

New Enterprise Associates

🏥 Healthcare